Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Voshol

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|January 16, 2007
Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy numberCharles R Dean, Shubha Narayan, Joel Richards, et al.
Plos One|April 25, 2013
The tyrosine phosphatase PTPN14 is a negative regulator of YAP activityChrysiis Michaloglou, Waltraut Lehmann, Typhaine Martin, et al.
The Journal of Biological Chemistry|October 10, 2003
Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitorsHarry Towbin, Kenneth W Bair, James A DeCaprio, et al.
Proteomics|March 21, 2007
From proteomics to systems biology of bacterial pathogens: approaches, tools, and applicationsUwe Plikat, Hans Voshol, Yvonne Dangendorf, et al.
Science (New York, N.Y.)|February 6, 2016
CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiencyMichael Bidinosti, Paolo Botta, Sebastian Krüttner, et al.
Cancer Research|November 19, 2015
Maximizing the Efficacy of MAPK-Targeted Treatment in PTENLOF/BRAFMUT Melanoma through PI3K and IGF1R InhibitionBarbara Herkert, Audrey Kauffmann, Sandra Mollé, et al.
Cancer Research|November 7, 2023
CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung CancerAnirudh Prahallad, Andreas Weiss, Hans Voshol, et al.
Nature|January 10, 2017
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαAdrian Britschgi, Stephan Duss, Sungeun Kim, et al.
Cancer Discovery|June 12, 2012
Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependentRita Andraos, Zhiyan Qian, Débora Bonenfant, et al.
Journal of Medicinal Chemistry|December 18, 2009
N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymeraseZheng Yin, Yen-Liang Chen, Ravinder Reddy Kondreddi, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|January 16, 2007
Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy numberCharles R Dean, Shubha Narayan, Joel Richards, et al.
Plos One|April 25, 2013
The tyrosine phosphatase PTPN14 is a negative regulator of YAP activityChrysiis Michaloglou, Waltraut Lehmann, Typhaine Martin, et al.
The Journal of Biological Chemistry|October 10, 2003
Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitorsHarry Towbin, Kenneth W Bair, James A DeCaprio, et al.
Proteomics|March 21, 2007
From proteomics to systems biology of bacterial pathogens: approaches, tools, and applicationsUwe Plikat, Hans Voshol, Yvonne Dangendorf, et al.
Science (New York, N.Y.)|February 6, 2016
CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiencyMichael Bidinosti, Paolo Botta, Sebastian Krüttner, et al.
Cancer Research|November 19, 2015
Maximizing the Efficacy of MAPK-Targeted Treatment in PTENLOF/BRAFMUT Melanoma through PI3K and IGF1R InhibitionBarbara Herkert, Audrey Kauffmann, Sandra Mollé, et al.
Cancer Research|November 7, 2023
CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung CancerAnirudh Prahallad, Andreas Weiss, Hans Voshol, et al.
Nature|January 10, 2017
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαAdrian Britschgi, Stephan Duss, Sungeun Kim, et al.
Cancer Discovery|June 12, 2012
Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependentRita Andraos, Zhiyan Qian, Débora Bonenfant, et al.
Journal of Medicinal Chemistry|December 18, 2009
N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymeraseZheng Yin, Yen-Liang Chen, Ravinder Reddy Kondreddi, et al.
Pageof 4